Govt fast-tracks nod for vaccine
* Vaccines authorised by World health Organisation or Vaccine
Regulators in US ,Europe , UK and Japan would be granted an emergency use
approval in India mandating requirement of post-approval parallel bridging
clinical trials
* First 100 beneficiaries of such vaccines shall be kept for
assessment for 7 daysfor safety outcomes before they are rolled out across the
entire country as per reports in the leading newspapers in India
* Among the healthcare giants , one of the largest drug
manufacturing organisation Pfizer has a production capacity of 2.5 billion
doses per annum and almost 1.6 billion confirmed dose purchases . From this one
can confer that India has 900 million doses that India could tap into for
procurement.
* Moderna and Johnson&Johnson
, two of the largest drug manufacturers and retailers have also bid in equal
terms for the same and in the process have taken in more orders than what could
be produced
* On 12th April , Govt of India also granted permission
permission for restricted emergency use of Russian vaccine Sputnik V
* The aforementioned regulatory approvals are intended to
increase the availability of the jabs amidst a steep second wave of the
infection .
* The vaccines can be imported in a ready- to use vial cylinder
bottles or in the form of fill and use form
No comments:
Post a Comment